Oz, Trump’s Medicare Nominee, Pledges to Divest Interests in Health Care Stocks

Published On Feb 19, 2025, 5:52 PM

Dr. Mehmet Oz, a high-profile figure recently nominated to lead the Centers for Medicare and Medicaid Services, disclosed that he will divest from numerous health-related investments, including a lucrative holding in the supplement company iHerb. His investments also span various healthcare stocks and artificial intelligence companies. The move comes amid scrutiny as he prepares for confirmation by the Senate, with his iHerb investment estimated between $5 million to $25 million. It remains uncertain when exactly he will sell these holdings, although he has committed to divesting within 90 days post-confirmation.

Stock Forecasts

XLV

Negative

Investors in healthcare stocks should monitor this situation closely, as any legislative changes or shifts in Medicare and Medicaid policies under Dr. Oz might affect related healthcare stocks negatively. Increased scrutiny on Oz may lead to a broader sell-off in the healthcare sector.

Related News

Asked for her views on pro-labor legislation she backed as a House Republican, Lori Chavez-DeRemer said she would simply serve the president’s agenda.

Investors have largely abandoned much of the healthcare space in favor of tech. But as tech falters, some strategists see the underrated sector as being the perfect tech hedge.

US stock futures pointed to sharp losses for the major indexes, as Wall Street showed the effects of President Donald Trump’s announcement of tariffs.

AAPL
TSLA
XLV
SPY